Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK EUR

Glanbia plc (GL9I.XC)

Compare
13.57
0.00
(0.00%)
At close: January 6 at 11:25:31 AM GMT
Loading Chart for GL9I.XC
DELL
  • Previous Close 13.57
  • Open 13.57
  • Bid --
  • Ask 18.93 x --
  • Day's Range 13.57 - 13.57
  • 52 Week Range 13.34 - 18.36
  • Volume 175
  • Avg. Volume 9
  • Market Cap (intraday) 3.618B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 12.68
  • EPS (TTM) 1.07
  • Earnings Date --
  • Forward Dividend & Yield 0.37 (2.72%)
  • Ex-Dividend Date Aug 22, 2024
  • 1y Target Est --

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

www.glanbia.com

5,534

Full Time Employees

December 30

Fiscal Year Ends

Recent News: GL9I.XC

View More

Performance Overview: GL9I.XC

Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

GL9I.XC
1.76%
ISEQ All Share
9.23%

1-Year Return

GL9I.XC
15.39%
ISEQ All Share
12.48%

3-Year Return

GL9I.XC
16.71%
ISEQ All Share
29.54%

5-Year Return

GL9I.XC
44.34%
ISEQ All Share
46.71%

Compare To: GL9I.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GL9I.XC

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    3.69B

  • Enterprise Value

    4.41B

  • Trailing P/E

    12.75

  • Forward P/E

    9.78

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.85

  • Price/Book (mrq)

    1.69

  • Enterprise Value/Revenue

    1.04

  • Enterprise Value/EBITDA

    8.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.58%

  • Return on Assets (ttm)

    6.05%

  • Return on Equity (ttm)

    14.10%

  • Revenue (ttm)

    4.47B

  • Net Income Avi to Common (ttm)

    297.3M

  • Diluted EPS (ttm)

    1.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    300.9M

  • Total Debt/Equity (mrq)

    48.90%

  • Levered Free Cash Flow (ttm)

    296.89M

Research Analysis: GL9I.XC

View More

Company Insights: GL9I.XC

Research Reports: GL9I.XC

View More